Sad but true. The executives managing the company in the USA have not kept pace with the evolution of the material and those who had knowledge are all gone. It’s not what you and I and many others invested in, when investors first went in from inception to 2010. Post 2010 the remaining brain drain was completed recently.
It’s why I posted my opinion in my last post in which trickle down exposure may rub off on LQMT as the basis for any realistic long term strategy for any growth in LQMT revenues.
It just can’t be based imo too, on the remaining USA executives as you clearly point out. Investing or one holding onto their shares in this high risk dice roll is based on everything outside of LQMT and what others are claiming to be doing in auto medical and consumer electronics, whether one realizes it or not.
None of those with theories and ridiculous predictions no longer base any of their opinions on direct LQMT released information. It’s obvious why. Their anemic volumes, the share price average and more importantly their actual contracts of inconsistency in revenues.
In essence the USA executives have nothing to show for all of their rhetoric. Where as executives outside of LQMT have much more and have a background in the material.
You mentioned DM. He would have been the more appropriate choice for interim ceo. However, all know why TC the least approved employee by shareholders was picked. Even BB, would have been much more appropriate. It is also so obvious why BB & BV were terminated. To be polite, let go, contracts not renewed.
What happened to any of those responsible for sales? Obviously zilch, zip, zero, by way of improving the value long term.
Good luck to you.
News 
Market Data 
Discover 
